Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis-Reference-Cited by-同舟云学术

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis

Published:2000-08 Issue:2 Volume:106 Page:253-259
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Ädelroth Ellinor,Rak Sabina,Haahtela Tari,Aasand Gunbjörn,Rosenhall Leif,Zetterstrom Olle,Byrne Aidan,Champain Kate,Thirlwell Jackie,Cioppa Giovanni Della,Sandström Thomas

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference28 articles.

1. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks and use of asthma medication in the European Community Respiratory Health Survey (ECRHS);European Community Respiratory Health Survey;Eur Respir J,1996

2. World-wide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. ISAAC;The International Study of Asthma and Allergies in Childhood ISAAC Steering Committee;Lancet,1998

3. Epidemiology of rhinitis and asthma;Lundback;Clin Exp Allergy,1998

4. Epidemiology of the allergic diseases: are they really on the increase?;Wütrich;Int Arch Allergy Immunol,1989

5. Evidence for an increase in atopic disease and possible causes;Bousquet;Clin Exp Allergy,1993

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial;Frontiers in Immunology;2024-07-29

2. Comparison of the therapeutic effects of medication therapy, specific immunotherapy and anti-IgE (Omalizumab) in patients with hay fever;Frontiers in Immunology;2024-02-28

3. Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma;The AAPS Journal;2023-06-02

4. Adverse Events for Monoclonal Antibodies in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Journal of Clinical Medicine;2023-04-13

5. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06